人黑素浓集素受体1抗原表位肽的表达、纯化及其在白癜风患者中的检测

中华皮肤科杂志 ›› 2010, Vol. 43 ›› Issue (12): 851-854.

人黑素浓集素受体1抗原表位肽的表达、纯化及其在白癜风患者中的检测

关翠萍¹,周妙妮²,林福全¹,许文³,洪为松¹,傅丽芳³,许爱娥⁴

1. 杭州市第三人民医院
2. 杭州市第三人民医院皮肤科
3.
4. 安徽医科大学附属杭州市第三人民医院皮肤科

收稿日期:2010-04-13 修回日期:2010-07-27 出版日期:2010-12-15 发布日期:2010-12-13
通讯作者: 关翠萍 E-mail:imgcp@hotmail.com
基金资助:
Nrf2核转位对人黑素细胞生物学行为的调控研究;CpG-ODN经Akt/mTOR抗UVB诱导的角质形成细胞凋亡的保护机制研究;白癜风患者抗黑素细胞抗体靶抗原筛选及临床诊断研究

Expression, purification of epitope peptide of human melanin-concentrating hormone receptor 1 and its antigenicity detection in vitiligo patients

Received:2010-04-13 Revised:2010-07-27 Online:2010-12-15 Published:2010-12-13
Contact: Cuiping Guan E-mail:imgcp@hotmail.com

摘要/Abstract

摘要：

目的表达及纯化人黑素浓集素受体1抗原表位肽，探讨其在白癜风患者自身抗体检测中的应用。方法人黑素浓集素受体1抗原表位肽编码基因合成后克隆至原核表达载体pGEX-4T-2，转化大肠杆菌BL21菌株，异丙基-β-D-硫代半乳糖苷（IPTG）诱导蛋白表达，通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳（SDS-PAGE）分析和Western印迹鉴定目的蛋白表达。以提取的黑素细胞膜蛋白作为阻断抗原，进行阻断ELISA分析。以目的蛋白为抗原，检测100例进展期白癜风患者和30例正常人血清IgG抗体情况。结果成功构建重组表达载体，重组蛋白成功表达并纯化，上样量低于0.0625 μg时纯化率达100％。目的蛋白与白癜风患者血清IgG抗体间的结合能被天然黑素细胞膜抗原抑制。100例进展期白癜风患者血清中有36例与目的蛋白结合反应呈阳性。结论成功表达并纯化了人黑素浓集素受体1抗原表位肽，该目的蛋白能够结合白癜风患者血清中IgG抗体，可以用于抗人黑素浓集素受体1抗体的检测。

关键词: 白癜风, 黑素浓集素受体1, 克隆，分子

Abstract:

Objective To express and purify the epitope peptide of human melanin-concentrating hormone receptor 1, and to evaluate its performance in the detection of autoantibodies in vitiligo patients. Methods The target gene encoding the epitope peptide of human melanin-concentrating hormone receptor 1 was synthesized, cloned to prokaryotic expression vector pGEX-4T-2 which was then transferred to E.coli BL21. The protein expression was induced by isopropy-β-D-thiogalactoside （IPTG） and identified with sodium dodecyl sulfate polyacrylamide gel electrophoresis （SDS-PAGE） and Western blot. Blocking ELISA was carried out with membrane proteins extracted from melanocytes as the blocking antigen. The antigenicity of the peptide was detected in sera from 100 patients with progressive vitiligo and 30 healthy human controls. Results The recombinant expression vector was successfully constructed, and the target protein was successfully expressed in E.coli, which was evidenced by SDS-PAGE and Western blot. With the glutathione S-transferase （GST） purification kit, the purity of the recombinant protein reached 100％ when the sampling weight was less than 0.625 μg. The binding of the target protein with serum IgG antibodies from vitiligo patients could be blocked by natural membrane antigen of melanocytes. Of the 100 sera from patients with progressive vitiligo, 36 were reactive with the target protein. Conclusions The epitope peptide of human melanin-concentrating hormone receptor 1 has been successfully expressed and purified. The purified protein can bind with serum IgG antibodies from vitiligo patients, and may be applied to the detection of autoantibodies against human melanin-concentrating hormone receptor 1.

Key words: vitiligo, melanin-concentrating hormone receptor 1

关翠萍周妙妮林福全许文洪为松傅丽芳许爱娥. 人黑素浓集素受体1抗原表位肽的表达、纯化及其在白癜风患者中的检测[J]. 中华皮肤科杂志, 2010, 43(12): 851-854.

参考文献

[1]. Farrokhi S, Farsangi-Hojjat M, Noohpisheh MK, et al. Assessment of the immune system in 55 Iranian patients with vitiligo. J Eur Acad Dermatol Venereol, 2005, 19(6): 706-711. [2]. Song YH, Connor E, Li Y, et al. The role of tyrosinase in autoimmune vitiligo. Lancet, 1994, 344(8929): 1049-1052. [3]. Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol, 1996, 105(1): 84-88. [4]. Okamoto T, Irie RF, Fujii S, et al. Anti-tyrosinase-related protein-2 immune response in vitiligo and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol, 1998, 111(6): 1034-1039. [5]. Gavalas NG, Gottumukkala RVSRK, Gawkrodger DJ, et al. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Experimental Dermatology. 2009, 18(5): 454-463. [6]. Kemp EH, Waterman EA, Hawes BE, et al. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest, 2002, 109(7): 923-930. [7]. Gottumukkala RVSRK, Gavalas NG, Akhtar S, et al. Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients. Laboratory investigation, 2006, 86(8): 781-789. [8]. 贺秋豪, 高天文, 李春英, 等. 白癜风患者血清自身抗体IgG识别人轩素浓集素受体-1 B细胞表位的研究. 中华皮肤科杂志, 2005, 38(1): 29-31. [9]. Kemp EH, Gavalas NG, Gawkrodger DJ, et al. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmun Rev, 2007, 6(3): 138-142. [10]. 田艳丽, 李春英, 王刚, 等. In-cell PCR技术扩增白癜风自身抗体基因. 中华皮肤科杂志, 2006, 39(1): 38-40. [11]. 关翠萍, 周妙妮, 李永伟, 等. 人酪氨酸酶抗原表位肽的表达、纯化及在白癜风中的抗原性检测. 中华医学杂志, 2007, 87(34):2408-2411. [12]. 关翠萍, 陈斐斐, 周妙妮, 等. 三种表达肽检测进展期白癜风血清酪氨酸酶抗体的比较. 中华皮肤科杂志, 2009, 42(10): 677-680. [13]. Saito Y, Nothacker HP, Wang Z, et al. Molecular characterization of the melanin-concentration hormone receptor. Nature, 1999, 400 (6741): 265-269. [14]. Hoogduijn MJ, Ancans J, Suzuki I, et al. Melanin-concentrating hormone and its receptor are expressed and functional in human skin. Biochem Biophys Res Commun, 2002, 296(3): 698-701. [15]. Enerback C, Martinsson T, Inerlot A, et al. Evidence that HLA Cw6 ditermines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). Acta Derm Venereol, 1997, 77(4): 273-276.